<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="events dependent on caspases activation and PARP cleavage in human" exact="colon cancer" post="cells through decreased protein expressions Guesmi Fatma 1 2"/>
 <result pre="dependent on caspases activation and PARP cleavage in human colon" exact="cancer" post="cells through decreased protein expressions Guesmi Fatma 1 2"/>
 <result pre="and Hydrophilic fractions of Teucrium alopecurus in the context of" exact="cancer" post="prevention and therapy. The goal was also to elucidate"/>
 <result pre="the molecular mechanisms involved and to determine its efficacy against" exact="cancer" post="by triggering apoptosis and suppressing tumorigenesis in human colon"/>
 <result pre="against cancer by triggering apoptosis and suppressing tumorigenesis in human" exact="colon cancer." post="The data here clearly demonstrated that oily fractions of"/>
 <result pre="involved in survival, proliferation, invasion, angiogenesis, and metastasis in human" exact="colon cancer" post="cells. No sign of toxicity was detected in vivo"/>
 <result pre="in survival, proliferation, invasion, angiogenesis, and metastasis in human colon" exact="cancer" post="cells. No sign of toxicity was detected in vivo"/>
 <result pre="the anticancer activity of Teucrium alopecurus oil mediated through the" exact="suppression" post="of cell growth, cell proliferation, and the induction of"/>
 <result pre="cell growth, cell proliferation, and the induction of apoptosis of" exact="cancer" post="cells. Thus, it has potential to be developed as"/>
 <result pre="are warranted. Teucrium alopecurus oily fractions water soluble fractions human" exact="colon cancer" post="cells gene expression INTRODUCTION Colonic carcinoma, a multistage process"/>
 <result pre="warranted. Teucrium alopecurus oily fractions water soluble fractions human colon" exact="cancer" post="cells gene expression INTRODUCTION Colonic carcinoma, a multistage process"/>
 <result pre="drugs with terpenes could be of great clinical importance in" exact="cancer" post="therapy [ 2]. Colorectal cancer (CRC), one of the"/>
 <result pre="of great clinical importance in cancer therapy [ 2]. Colorectal" exact="cancer" post="(CRC), one of the most lethal cancers, especially when"/>
 <result pre="[ 10], against mouth, breast, lung, prostate, liver, colon, and" exact="brain cancer" post="and even leukemia [ 11– 16]. Numerous nutraceuticals from"/>
 <result pre="10], against mouth, breast, lung, prostate, liver, colon, and brain" exact="cancer" post="and even leukemia [ 11– 16]. Numerous nutraceuticals from"/>
 <result pre="breast, lung, prostate, liver, colon, and brain cancer and even" exact="leukemia" post="[ 11– 16]. Numerous nutraceuticals from &quot;mother nature&quot; could"/>
 <result pre="development [ 1] and have been shown to potentially halt" exact="cancer" post="progression by targeting one or more steps in the"/>
 <result pre="to treat a broad range of human diseases, including particularly" exact="cancer" post="and inflammation [ 23]. The whole botanical may be"/>
 <result pre="anticancer properties [ 25]. T. polium protects liver cells against" exact="hepatocellular carcinoma" post="in carcinogenesis-induced animal models [ 26]. It has been"/>
 <result pre="shown to be an effective and safe chemosensitizer agent for" exact="cancer" post="therapy [ 25]. This report describes novel insight into"/>
 <result pre="and hydrolate (TA-2) of Teucrium alopecurus as an alternative complementary" exact="cancer" post="treatment, and, in order to elucidate its potential activity"/>
 <result pre="cytotoxic. TA-1 and hydrophilic fraction (TA-2) represses the proliferation of" exact="colorectal cancer" post="cells Figure 1E shows the concentration- and time-dependent repression"/>
 <result pre="TA-1 and hydrophilic fraction (TA-2) represses the proliferation of colorectal" exact="cancer" post="cells Figure 1E shows the concentration- and time-dependent repression"/>
 <result pre="time-dependent repression of tumour cell proliferation induced by Teucrium. Breast" exact="cancer" post="cells (MCF-7) and pancreatic carcinoma (Panc28) cells are the"/>
 <result pre="to the vehicle control (Figure 1E, upper panel). Chronic myelogenous" exact="leukemia" post="(KBM-5) and human colon cancer cells (HCT116) cells have"/>
 <result pre="(Figure 1E, upper panel). Chronic myelogenous leukemia (KBM-5) and human" exact="colon cancer" post="cells (HCT116) cells have a moderate sensitivity to this"/>
 <result pre="1E, upper panel). Chronic myelogenous leukemia (KBM-5) and human colon" exact="cancer" post="cells (HCT116) cells have a moderate sensitivity to this"/>
 <result pre="this essential oil. In addition, TA-2 suppresses the proliferation of" exact="cancer" post="cells (Figure 1D, lower panel). Teucrium fractions decrease clonogenic"/>
 <result pre="and hydrophilic fractions of Teucrium suppresses the clonogenic potential of" exact="colon cancer" post="cells. HCT-116 cell lines were very resistant to low"/>
 <result pre="hydrophilic fractions of Teucrium suppresses the clonogenic potential of colon" exact="cancer" post="cells. HCT-116 cell lines were very resistant to low"/>
 <result pre="TA-1 compared to the control (MFI 114.2) was observed in" exact="colon cancer" post="cells (Left panel). However, very low amounts (non-significant) of"/>
 <result pre="compared to the control (MFI 114.2) was observed in colon" exact="cancer" post="cells (Left panel). However, very low amounts (non-significant) of"/>
 <result pre="microscope (Labophot-2; Nikon, Tokyo, Japan). Percentages are proportions of apoptotic" exact="cancer" post="cells. The results are representative of three independent experiments."/>
 <result pre="time-dependent manner (Figure 4 (Ai–Aii) and 4B), thus indicating that" exact="colorectal cancer" post="cells are undergoing apoptosis. Figure 4 TA-1 and TA-2"/>
 <result pre="manner (Figure 4 (Ai–Aii) and 4B), thus indicating that colorectal" exact="cancer" post="cells are undergoing apoptosis. Figure 4 TA-1 and TA-2"/>
 <result pre="involved in the antiapoptotic, proliferation, metastasis, invasion and angiogenesis of" exact="colorectal cancer" post="cells The down-regulation of multiple gene products obtained from"/>
 <result pre="in the antiapoptotic, proliferation, metastasis, invasion and angiogenesis of colorectal" exact="cancer" post="cells The down-regulation of multiple gene products obtained from"/>
 <result pre="with TA-1. Western blotting and relative densitometric analyses of the" exact="suppression" post="of antiapoptotic, proliferative, and metastatic gene products and the"/>
 <result pre="Cii)). TA-1 suppresses constitutive STAT3 activation in HCT-116 cells Colorectal" exact="cancer" post="cells express constitutively active STAT3 [ 27]. Upon exposing"/>
 <result pre="as inflammatory agent (Figure 8A) used to induce inflammation and" exact="cancer" post="in colon cells. After experimental analysis, LPS was shown"/>
 <result pre="to antitumor activity by abrogating the STAT3 signaling pathway in" exact="colon cancer" post="cells. An increased level of apoptotic CRC cells was"/>
 <result pre="antitumor activity by abrogating the STAT3 signaling pathway in colon" exact="cancer" post="cells. An increased level of apoptotic CRC cells was"/>
 <result pre="potential of β-pinene was investigated in MCF-7, A375, and HepG2" exact="cancer" post="cells and in other different tumor and nontumor cell"/>
 <result pre="[ 37]. In fact, the studies of the cytotoxicity of" exact="cancer" post="cell lines towards essential oils demonstrate a great difference"/>
 <result pre="TA-1. Various cell cycle checkpoints act as potential targets for" exact="cancer" post="treatment [ 10]. Several nutraceuticals prevent cancer cells from"/>
 <result pre="potential targets for cancer treatment [ 10]. Several nutraceuticals prevent" exact="cancer" post="cells from transitioning from the G1 to S phase."/>
 <result pre="as effective anticancer substances by targeting cell cycle progression in" exact="cancer" post="cells [ 10]. In colorectal cancer cells, the maximal"/>
 <result pre="targeting cell cycle progression in cancer cells [ 10]. In" exact="colorectal cancer" post="cells, the maximal alteration in cancer cell cycle progression"/>
 <result pre="cell cycle progression in cancer cells [ 10]. In colorectal" exact="cancer" post="cells, the maximal alteration in cancer cell cycle progression"/>
 <result pre="[ 10]. In colorectal cancer cells, the maximal alteration in" exact="cancer" post="cell cycle progression in the G2/M phase promoted by"/>
 <result pre="as effective anticancer substances by targeting cell cycle progression in" exact="cancer" post="cells [ 10]. Thymol, a phenolic compound of Teucrium"/>
 <result pre="cells. Hydrophobic and hydrophylic fractions decreased cell proliferation in human" exact="colon cancer" post="cells through a decrease of Cyclin D1 and p21."/>
 <result pre="Hydrophobic and hydrophylic fractions decreased cell proliferation in human colon" exact="cancer" post="cells through a decrease of Cyclin D1 and p21."/>
 <result pre="alcohol, and (+)-epi-Bicyclosesquiphellandrene. In a further study on highly malignant" exact="glioma" post="cells, Edris [ 20] evaluated that α-Bisabolol is considered"/>
 <result pre="antiproliferative effects comparable to those of curcumin in human leukemia," exact="multiple myeloma," post="and colorectal cancer cells. d-limonene, as a constituent of"/>
 <result pre="to those of curcumin in human leukemia, multiple myeloma, and" exact="colorectal cancer" post="cells. d-limonene, as a constituent of TA-1 in a"/>
 <result pre="those of curcumin in human leukemia, multiple myeloma, and colorectal" exact="cancer" post="cells. d-limonene, as a constituent of TA-1 in a"/>
 <result pre="shown to be an effective and safe chemosensitizer agent for" exact="cancer" post="therapy [ 25]. It is interesting to note that"/>
 <result pre="to the change of the DNA repair process in the" exact="cancer" post="cells [ 10]. Proteolytic cleavage of PARP activated caspases"/>
 <result pre="43]. An intrinsic pathway was activated in Limonene treated LS174T" exact="colon cancer" post="cells [ 44]. Some EOs and their components inhibit"/>
 <result pre="An intrinsic pathway was activated in Limonene treated LS174T colon" exact="cancer" post="cells [ 44]. Some EOs and their components inhibit"/>
 <result pre="cells by downregulating the expression of cyclin D1, myeloid cell" exact="leukemia" post="(Mcl-1), X-chromosome-linked IAP (XIAP), IAP-1, IAP-2, and B cell"/>
 <result pre="leukemia (Mcl-1), X-chromosome-linked IAP (XIAP), IAP-1, IAP-2, and B cell" exact="lymphoma" post="extra large (BcL-xL) levels. Bcl-2 protein is downregulated by"/>
 <result pre="is downregulated by the action of TA-1 on the HCT-116" exact="cancer" post="cells in a dose- and time-dependent manner. The results"/>
 <result pre="were reported by Gupta et al. [ 47] in three" exact="colon cancer" post="cell lines (HCT-116, Caco-2, and HT-29) that were inhibited"/>
 <result pre="reported by Gupta et al. [ 47] in three colon" exact="cancer" post="cell lines (HCT-116, Caco-2, and HT-29) that were inhibited"/>
 <result pre="protein STAT-3 (at Tyr 705 and Ser 727) in human" exact="colon cancer" post="cells in a dose- and time-dependent manner. This data"/>
 <result pre="STAT-3 (at Tyr 705 and Ser 727) in human colon" exact="cancer" post="cells in a dose- and time-dependent manner. This data"/>
 <result pre="49]. STAT-3 is overexpressed in several tumor cells, including cholangiocarcinoma," exact="breast cancer," post="prostate cancer, head and neck squamous cell carcinoma, lymphomas"/>
 <result pre="is overexpressed in several tumor cells, including cholangiocarcinoma, breast cancer," exact="prostate cancer," post="head and neck squamous cell carcinoma, lymphomas and leukemia,"/>
 <result pre="squamous cell carcinoma, lymphomas and leukemia, brain tumors, gastric cancer," exact="esophageal cancer," post="ovarian cancer, nasopharyngeal cancer, and pancreatic cancer [ 27]."/>
 <result pre="carcinoma, lymphomas and leukemia, brain tumors, gastric cancer, esophageal cancer," exact="ovarian cancer," post="nasopharyngeal cancer, and pancreatic cancer [ 27]. In addition,"/>
 <result pre="tumors, gastric cancer, esophageal cancer, ovarian cancer, nasopharyngeal cancer, and" exact="pancreatic cancer" post="[ 27]. In addition, Teucrium ethereal oil was also"/>
 <result pre="gastric cancer, esophageal cancer, ovarian cancer, nasopharyngeal cancer, and pancreatic" exact="cancer" post="[ 27]. In addition, Teucrium ethereal oil was also"/>
 <result pre="able to express proteins involved in the angiogenic phenotypes of" exact="cancer" post="cells on tumor invasion and the metastasis of human"/>
 <result pre="cancer cells on tumor invasion and the metastasis of human" exact="colon cancer" post="cells in vitro by reducing CXC chemokine receptor 4"/>
 <result pre="cells on tumor invasion and the metastasis of human colon" exact="cancer" post="cells in vitro by reducing CXC chemokine receptor 4"/>
 <result pre="the antiangiogenic effect of d-limonene with a preventative effect on" exact="colon cancer." post="Jung et al. [ 52] showed that epigallocatechin gallate"/>
 <result pre="through the inhibition of ERK-1 and ERK-2 kinases in human" exact="colon cancer" post="cells. c-myc as a cell cycle component is down-regulated"/>
 <result pre="the inhibition of ERK-1 and ERK-2 kinases in human colon" exact="cancer" post="cells. c-myc as a cell cycle component is down-regulated"/>
 <result pre="the proliferation, invasion, and metastasis of Panc28, Miapaca, and HL60" exact="cancer" post="cells by down-regulating Bcl-xL, XIAP, survivin, MMP-9, and CXCR4"/>
 <result pre="and caspase-independent pathways. A recent finding about d-limonene and elemene" exact="colon cancer" post="treatment was obtained from LS174T and Lovo cells with"/>
 <result pre="caspase-independent pathways. A recent finding about d-limonene and elemene colon" exact="cancer" post="treatment was obtained from LS174T and Lovo cells with"/>
 <result pre="demonstrate the relevance of these results obtained in vitro to" exact="cancer" post="treatment. Essential oil of Teucrium is a potential therapeutic"/>
 <result pre="from the American Type Culture Collection (Manassas, VA, USA). Human" exact="colon cancer" post="cells, human pancreatic carcinoma, pancreatic carcinoma, human head and"/>
 <result pre="the American Type Culture Collection (Manassas, VA, USA). Human colon" exact="cancer" post="cells, human pancreatic carcinoma, pancreatic carcinoma, human head and"/>
 <result pre="Human colon cancer cells, human pancreatic carcinoma, pancreatic carcinoma, human" exact="head and neck cancer," post="and RAW cells were cultured in Dulbecco's modified Eagle's"/>
 <result pre="Aggarwal [ 65]. Production of ROS levels in HCT116 Colon" exact="cancer" post="cells (1 × 10 6 cells) cells were labeled"/>
 <result pre="to bend to specific antibodies. Cell extracts (treated and untreated" exact="cancer" post="cells, normal cells) were prepared in lysis buffer (20"/>
 <result pre="salt 3-(4-5-dimethylthiozol-2-yl)2-5-diphenyl-tetrazolium bromide VEGF Anti–vascular endothelial growth factor Bcl-xL B-cell" exact="leukemia" post="protein xL cIAP Cellular inhibitor of apoptosis protein PARP"/>
 <result pre="Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of" exact="colorectal cancer" post="through activation of STAT3 Signalling Mol Cell Biochem 2016"/>
 <result pre="protein (VCP) promotes the growth, invasion, and metastasis of colorectal" exact="cancer" post="through activation of STAT3 Signalling Mol Cell Biochem 2016"/>
 <result pre="from herbal plants and citrus fruits on DNA polymerase inhibitory," exact="cancer" post="cell growth inhibitory, antiallergic, and antioxidant activities J Agric"/>
 <result pre="of volatile oil from Citrus limettioides and their inhibition of" exact="colon cancer" post="cell proliferation Ind Crops Prod 2013 45 200 207"/>
 <result pre="volatile oil from Citrus limettioides and their inhibition of colon" exact="cancer" post="cell proliferation Ind Crops Prod 2013 45 200 207"/>
 <result pre="essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7" exact="cancer" post="cells Molecules 2010 15 3200 3210 20657472 17 Ferraz"/>
 <result pre="acetate in cytotoxicity induced by bergamot essential oil in human" exact="neuroblastoma" post="cells Fitoterapia 2013 89 48 57 23707744 19 Jo"/>
 <result pre="via ROS generation and activation of caspases in YD-8 human" exact="oral cancer" post="cells Int J Oncol 2012 40 1238 45 22086183"/>
 <result pre="ROS generation and activation of caspases in YD-8 human oral" exact="cancer" post="cells Int J Oncol 2012 40 1238 45 22086183"/>
 <result pre="by pentacyclic triterpenoids: potential role in prevention and therapy of" exact="cancer" post="Cancer Lett 2012 320 158 170 22406826 24 Tutin"/>
 <result pre="BB Curcumin suppresses proliferation and induces apoptosis in human biliary" exact="cancer" post="cells through modulation of multiple cell signaling pathways Carcinogenesis"/>
 <result pre="Zhuang YZ Anti-proliferative and pro-apoptotic effect of carvacrol on human" exact="hepatocellular carcinoma" post="cell line HepG-2 Cytotechnology 2012 64 43 51 21938469"/>
 <result pre="Evaluation of cytotoxic effect of Teucrium polium on a new" exact="glioblastoma multiforme" post="cell line (REYF-1) using MTT and soft agar clonogenic"/>
 <result pre="Lara PN Jr de Vere White RW Combination treatment of" exact="prostate cancer" post="cell lines with bioactive soy isoflavones and perifosine causes"/>
 <result pre="PN Jr de Vere White RW Combination treatment of prostate" exact="cancer" post="cell lines with bioactive soy isoflavones and perifosine causes"/>
 <result pre="D-limonene is mediated by inactivation of Akt in LS174T human" exact="colon cancer" post="cells Oncol Rep 2013 29 349 54 23117412 45"/>
 <result pre="is mediated by inactivation of Akt in LS174T human colon" exact="cancer" post="cells Oncol Rep 2013 29 349 54 23117412 45"/>
 <result pre="contributes to gefitinib resistance via upregulation of STAT3 activation in" exact="colorectal cancer" post="Sci Rep 2015 5 16082 26542452 50 Vendramini-Costa DB"/>
 <result pre="to gefitinib resistance via upregulation of STAT3 activation in colorectal" exact="cancer" post="Sci Rep 2015 5 16082 26542452 50 Vendramini-Costa DB"/>
 <result pre="Vendramini-Costa DB Carvalho JE Molecular link mechanisms between inflammation and" exact="cancer" post="Curr Pharm Des 2012 18 3831 3852 22632748 51"/>
 <result pre="Shivappa Mantur MB Citrus monoterpenes: potential source of phytochemicals for" exact="cancer" post="prevention Em erging Trends in Dietary Components for Preventing"/>
 <result pre="Pollard JW Therapeutic potential of chemokine signal inhibition for metastatic" exact="breast cancer" post="Pharmacol Res 2015 100 266 270 26275794 54 Deb"/>
 <result pre="JW Therapeutic potential of chemokine signal inhibition for metastatic breast" exact="cancer" post="Pharmacol Res 2015 100 266 270 26275794 54 Deb"/>
 <result pre="thymol on peripheral blood mononuclear cell PBMC and acute promyelotic" exact="cancer" post="cell line HL-60 Chem Biol Interact 2011 193 97"/>
 <result pre="on the telomerase activity, apoptosis and cell cycles of the" exact="colon cancer" post="lovo cell line Herald Med 2004 10 713 715"/>
 <result pre="the telomerase activity, apoptosis and cell cycles of the colon" exact="cancer" post="lovo cell line Herald Med 2004 10 713 715"/>
 <result pre="M Lipopolysaccharide induces inflammation and facilitates lung metastasis in a" exact="breast cancer" post="model via the prostaglandin E2-EP2 pathway Mol Med Rep"/>
 <result pre="Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast" exact="cancer" post="model via the prostaglandin E2-EP2 pathway Mol Med Rep"/>
 <result pre="F Shen YN Hu ZQ Aspirin inhibited the metastasis of" exact="colon cancer" post="cells by inhibiting the expression of toll-like receptor 4"/>
 <result pre="Shen YN Hu ZQ Aspirin inhibited the metastasis of colon" exact="cancer" post="cells by inhibiting the expression of toll-like receptor 4"/>
</results>
